Oxidative modification of plasma lipoproteins increases their atherogenicity. Nutritive antioxidants, including carotenoids, can prevent such lipoperoxidation and may protect against atherosclerosis. Plasma retinol, ascorbate, ct-tocopherol and four carotenoids (lutein, lycopene, a-carotene and /7-carotene) were measured using HPLC in 45 patients with chronic renal failure (CRF) and in 21 controls. Plasma retinol was significantly increased in patients with CRF (conservative therapy mean of 3.7 jimol/l vs. 1.9|imol/l; p < 0.001). Plasma lycopene was significantly lower in patients with CRF (healthy mean 0.44 umol/l vs. conservative therapy mean 0.27 u.mol/1 and haemodialysis mean of 0.17 fimol/l; p < 0.001), a finding that persisted even after adjusting for plasma cholesterol. Low circulating antioxidant lycopene levels may contribute to an already impaired antioxidant defence system in patients with CRF. The process of haemodialysis further compromises antioxidant defences, principally by removing water-soluble ascorbate and urate, but does not appear to affect circulating carotenoid concentrations.
Introduction
Cardiovascular disease is a major cause of morbidity and mortality in people with chronic renal disease, even those on long-term renal replacement therapy. The high prevalence of hypertension, together with abnormal lipid profiles commonly seen in this population can be important factors. However, evidence is accumulating that increased free-radical activity leading to increased lipid peroxidation may also be important, especially in those on haemodialysis therapy. 1 ' 2 To counter damaging free-radical activity, the body has an integrated system of protective antioxidant enzymes and micronutrients to prevent freeradical formation and proliferation. 3 In chronic renal failure (CRF), however, multiple abnormalities of this system have been reported. Levels of antioxidant enzymes such as glutathione peroxidase have been reported to be lower in those on maintenance haemodialysis. 4 ' 5 Of great importance in renal failure are the crucial antioxidants that can be obtained only from dietary sources, e.g. ascorbate (vitamin C), a-tocopherol (vitamin E) and carotenoids. Because of the dietary restrictions on fruit and vegetable intake often imposed on patients with chronic renal failure, deficiencies of these antioxidants may be more common. The first aim of this study was to determine if patients with chronic renal failure had altered plasma antioxidant vitamin and carotenoid status. Secondly, because the procedure of haemodialysis itself may adversely affect the oxidative milieu in plasma by increasing free-radical production 6 and by removal of water-soluble factors such as ascorbate, the acute effect of haemodialysis on antioxidant status and carotenoids was investigated.
Methods
Forty-five patients with different degrees of CRF were recruited from the outpatient population of the Renal Unit, Royal Infirmary, Glasgow. Eighteen of these patients were on maintenance haemodialysis therapy (three smokers), while the remainder were on conservative therapy (four smokers). Patients with active inflammatory conditions and hepatic disease were excluded. All haemodialysis patients had been on regular haemodialysis for at least 6 months (mean 36 months). They were dialysed three times per week each for 3-5 h using cuprammonium cellulose (n = 15) and cuprammonium rayon (n = 3) dialysis membranes. All patients had been seen by a renal specialist dietitian when chronic renal failure was first diagnosed, and were prescribed diets restricted in protein to 1 g/kg ideal body weight/day. If hyperkalaemia was present, they were also advised to consume no more than three servings of fruit, and no more than two servings of boiled vegetables daily in order to restrict potassium intake. All patients on haemodialysis were prescribed daily supplements of ascorbic acid (100 mg/day) and vitamin B complex (Becosym Forte, Roche). For a comparison group, 21 nonsmoking, healthy, adult controls were recruited. Control subjects were younger than patients (mean 36 years), but in a parallel study (unpublished data) we have found no effect of age on plasma carotenoids in 92 healthy individuals.
A 10 ml sample of non-fasting venous blood was collected from patients and controls. Routine biochemical data were additionally available for patients from data on electronic patient records.
To study the acute effects of haemodialysis, 15 non-smoking patients on haemodialysis therapy were selected. From these patients, 10 ml arterial blood was obtained immediately before and after haemodialysis. After collection, all blood samples were separated by centrifugation at 2000 rpm within 60 min of collection. Samples of plasma were stored at -70 C until assay. Total retinol, a-tocopherol and carotenoids, 7 and ascorbate 8 were measured by highperformance liquid chromatography. The method described by Miller et a\? was used to assess the total plasma antioxidant capacity (TAC) pre-and post-dialysis, to provide an in vitro index of the combined free-radical quenching capability of all antioxidant compounds in plasma as compared to a standard mixture of antioxidant Trolox, an atocopherol analogue. The main contributors to total antioxidant capacity are believed to be plasma albumin, urate, bilirubin, ascorbate, a-tocopherol and other antioxidants including carotenoids, glutathione, ubiquinone and cysteine. Other biochemical parameters were measured by standard laboratory tests.
All procedures were within the ethical guidelines of the Ethics Committee of the Glasgow Royal Infirmary University Trust. Groups were compared using the Mann-Whitney-U test available on Minitab series 10.
Results
Plasma albumin and urate were significantly higher in conservatively treated CRF patients ( Table 1 ). As shown in Table 2 , plasma retinol was significantly elevated in patients with CRF (p<0.001), especially those on haemodialysis. Plasma concentrations of lycopene were significantly lower in patients with CRF, especially those on haemodialysis (p<0.001). There were no statistically significant differences between either group with CRF and controls in absolute plasma concentrations of a or j? carotene or lutein.
Plasma cholesterol concentration was significantly raised in those on conservative therapy, but those on maintenance haemodialysis had values no different from controls. Because the majority of carotenoids in plasma are bound to plasma lipoproteins, the carotenoid measurements were also adjusted for plasma cholesterol. The low plasma lycopene concentration in all patients with CRF remained even after cholesterol adjustment ( p < 0.002).
The process of haemodialysis did not acutely affect the plasma concentrations of retinol, a-tocopherol, a-carotene, /7-carotene, lutein and lycopene (Table 3) . Haemodialysis acutely reduced plasma total ascorbate (p<0.0001) and urate (p<0.001) in every patient. The pre-dialysis mean total antioxidant capacity of plasma was increased compared to healthy controls (p<0.04). There was a significant (p<0.0005) acute reduction in the mean TAC score with haemodialysis, and the post-dialysis figure was significantly lower than in healthy controls (p<0.006). Pre-dialysis plasma ascorbate was already significantly lower than in the control population ( p < 0.006).
Discussion
The normal antioxidant defence system depends on the synergistic interactions of multiple antioxidants for optimal protection against damaging radicals.
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With reported deficiencies of enzymic antioxidants, selenium, ascorbate and reduced circulating lycopene, patients with CRF have multiple important abnormalities in their antioxidant defence system. 1 '
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These abnormalities will increase their susceptibility to lipoperoxidation and possibly contribute to subsequent atherosclerosis.
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The data presented here show a clear disruption of normal vitamin and carotenoid metabolism in CRF. Loughrey et al. previously described normal plasma j9-carotene status in patients with CRF. 5 We confirm this finding and extend it to plasma acarotene and lutein. However, a significant deficiency of lycopene was found in all CRF patients. We did not measure dietary carotene intake in this study, as dietary advice for fruit and vegetable intake (the main sources of carotenes) given to CRF patients was not different from the relatively low average consumption of fruit and vegetables in the West of Scotland. 12 In addition, circulating lutein concentrations are a good biomarker of carotene intake 13 (own unpublished data). As plasma lutein levels were similar in all three groups, the carotene intake of patients with CRF and that of healthy subjects are unlikely to have been significantly different. In the presence of normal gastrointestinal absorption, the isolated low plasma lycopene can probably only be explained by considering the abnormal oxidative milieu reported to be present in renal failure. Different carotenoids are known to have different abilities as antioxidants, and in vitro, lycopene is the most reactive antioxidant carotenoid found in physiological amounts in humans, 14 ' 15 followed by a-carotene and /^-carotene. It is plausible that increased free-radical activity associated with renal dysfunction may initially affect lycopene before affecting a-carotene, /^-carotene, lutein or atocopherol.
That neither a-carotene nor /^-carotene are lowered by oxidative consumption may be explained by their additional metabolic role as retinol precursors. Retinol (vitamin A) has a central role in cell metabolism and is normally under tight homoeostatic control. 16 It is transported in plasma bound to retinolbinding protein (RBP), and is only active after separation from its binding protein. In established renal failure, RBP is retained and plasma total retinol concentration increases. 17 Stein et a/. 18 noted that despite elevated serum retinol, there was no increase in tissue level vitamin A in uraemic patients, suggesting that intracellular free retinol levels can be controlled by down-regulating RBP-retinol uptake. However, if sepsis occurs to reduce hepatic release of RBP, the plasma free retinol concentration (which can bypass the membrane RBP-receptor system) increases. This can occasionally be associated with clinical toxicity in patients with renal failure. 19 Therefore, to reduce the risk of vitamin A toxicity, it is proposed that negative feedback from high retinol concentrations prevents further enzymic conversion of a-and /f-carotene to retinol (Figure 1 ). Plasma levels of a-and j5-carotene in CRF thus reflect the balance between this phenomenon and oxidative catabolism.
As patients on haemodialysis have been reported to be most at risk of oxidative stress, 2 ' 4 and in this study had the lowest plasma lycopene concentrations, the second experiment determined whether Figure 1 . Carotenoid metabolism in chronic renal failure haemodialysis acutely reduced plasma carotene levels. Haemodialysis did not reduce plasma carotenoid, nor retinol or a-tocopherol levels. In healthy subjects, abundant plasma urate and albumin together account for 75% of in vitro total plasma antioxidant capacity, with ascorbate contributing 10% and a-tocopherol 3%. 9 The abnormally high levels of plasma urate in CRF account for the high measured in vitro total plasma antioxidant capacity. Due to a sudden reduction in circulating levels of plasma urate and ascorbate, the measured plasma total antioxidant capacity plummets after haemodialysis to levels significantly lower than that measured in healthy plasma. These findings support those of Jackson et a/. 20 Such post-dialysis reductions in total plasma antioxidant defence capability may expose haemodialysis-treated patients to periods of particularly increased susceptibility to lipid peroxidation. For patients with renal failure, who are at risk of deficiency and subsequent complications because of their dietary limitations and altered metabolism, vitamin and micronutrient supplementation is an important issue that needs to be addressed. In Glasgow, supplements of ascorbic acid in physiological amounts are provided daily. As a practical conclusion of this study, the ascorbic acid supplement should be given routinely after haemodialysis. Excessive ascorbic acid supplementation ( > 1 g/day) should, however, be avoided because of the risk of promoting calcium oxalate production. 21 Trials of antioxidant carotenoid supplementation to prevent CVD in high-risk groups are currently limited to pharmacological doses of /^-carotene, and the results so far have been conflicting. 22 In addition, supplementation with pharmacological doses of /?-carotene in smokers has been associated with increased lung cancer deaths. 23 Anxieties also surround the selection of specific nutrients for supplementation from the large number of bioactive compounds in fruit and vegetables. Patients with CRF should continue to have an adequate intake of fruit and vegetables, as they contain many beneficial nutrients including lycopene. However, the amount of fruit and vegetables that can safely be eaten to avoid hyperkalaemia needs to be clearly defined under the modern management of renal failure.
